Berkeley Lights is developing a patient-centric therapeutic approach: an integrated, self-contained platform that will enable a fully automated process for the delivery of cellular therapy protocols. The entire process – from cloning, assay activation, expansion, and quality control – will be delivered in a single platform.
Cellular Therapies Today
Cell therapies have the potential to manage and cure a wide range of diseases. Manufacturing of therapies from a patient’s own cells presents unique challenges in quality, scalability, and logistical requirements. To address those challenges innovations in manufacturing are needed.